periodontitis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Chronic periodotitis patients that completed initial therapy and prosthetic treatments and has a tooth with probing depth 6 mm or more and bleeding on probing 3 times at four weeks or more intervals
Exclusion criteria
Exclusion criteria: Patients that hypersensitivity is suspected to cetylpyridinium chloride hydrate. Patients that are given medicine causing extention or shortening of bleeding time. Patient with the disease to cause extention or shortening of the bleeding time. Patient who is given an anticancer drug. The patient who is given a steroid. Patient having more than 7.0% of HbA1C. The patient who was given antimicrobial within six months. Patient with gingival hyperplasia. Patient who received the subgingival ultrasonic irrigation using the drug within six months. Patient with the periodontal abscess.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Disappearance ratio of bleeding on probing after 8 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| The number of P.gingivalis, T.forsythensis and T.denticola in the pockets | — |
Countries
Japan
Contacts
Hokkaido University Hospital Periodontics and Endodontics